Legal barriers exist for many good reasons, but can block our pathway in making the changes needed to help patients in the current climate. The panel addresses:

Protocols that require approval from legal and compliance
R&D and compliance, breaking down the silos and working jointly for patient needs
How to bring the patient voice to legal and compliance initiatives that impact patients?
What are the next steps? What initiatives could legal/compliance be a part of with patient engagement to gain an understanding of the impact and urgency of their approvals?

Led by:
Marilyn Metcalf, PhD, Senior Director, Patient-Focused Development, Global Medical, GSK

Panelists:

Roslyn Schneider MD, VP, Scientific, Medical and Patient Affairs, Theravance Biopharma US
Parthena Psyllos, Senior Corporate Counsel, Clinical Development Legal, Pfizer
Sue Gregory, Former Managing Counsel/Executive Director, GSK
Candace Lerman, Patient Advocate and Attorney
Kate Harr-Sponsler, Associate General Counsel – Global Commercial, Spark Therapeutics

Learn more about the Patients as Partners in Clinical Research conference at www.patientsaspartners.org

Patient Involvement Legal Barriers to Be Aware of and Pathways to Overcome Them

Share

Embed